SCHEMBL6890976

SCHEMBL6890976

NC(=O)n1c(-c2ccccc2)nc2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.56
HSD17B10 Q99714 3/20 0.56
CNR2 P34972 2/20 0.51
KMT2A Q03164 4/20 0.50
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
MEN1 O00255 2/20 0.50
MAOA P21397 1/20 0.49
ESR1 P03372 1/20 0.49
ESR2 Q92731 1/20 0.49
ALDH1A1 P00352 3/20 0.47
HPGD P15428 1/20 0.47
PDE6D O43924 1/20 0.47
ALDH2 P05091 1/20 0.47
ALDH3A1 P30838 1/20 0.47
LMNA P02545 2/20 0.47
TSHR P16473 1/20 0.47
JAK2 O60674 2/20 0.46
JAK1 P23458 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29145105 0.89 KDM4E (0.56) KDM4EHSD17B10CNR2KMT2ANPC1
SCHEMBL28646061 0.89 ESR1 (0.52) KDM4EHSD17B10CNR2KMT2ANPC1
SCHEMBL29145129 0.88 KMT2A (0.61) KDM4ECNR2KMT2ANPC1RAB9A
SCHEMBL29145192 0.86 TP53 (0.52) KDM4EHSD17B10CNR2KMT2ANPC1
SCHEMBL6951818 0.86 KDM4E (0.59) KDM4EHSD17B10CNR2KMT2ANPC1
SCHEMBL29145131 0.84 CNR2 (0.50) KDM4EHSD17B10CNR2KMT2ANPC1
SCHEMBL29145102 0.84 CASR (0.52) KDM4EHSD17B10CNR2KMT2ANPC1
SCHEMBL29145098 0.84 KDM4E (0.52) KDM4EHSD17B10CNR2KMT2ANPC1
SCHEMBL1844163 0.83 KDM4E (0.49) KDM4EHSD17B10CNR2KMT2ANPC1
SCHEMBL29145109 0.83 ALDH1A1 (0.64) KDM4ECNR2KMT2ARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1391457-A1 Substituted 2-Phenylbenzimidazoles and their use as PARP inhibitors Abbott GmbH & Co. KG (DE) 2004-02-25 EP disclosed